Private Portfolio Partners LLC Dexcom Inc Transaction History

Private Portfolio Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $33,655 - $65,780	-495 Closed	0 $0
Q1 2022 Mar 14, 2023	BUY	$94.08 - $130.2 $4,609 - $6,379	49 Added 10.99%	495 $63,000
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $4,609 - $6,379	49 Added 10.99%	495 $253,000
Q4 2021 Mar 14, 2023	BUY	$129.87 - $162.82 $1,428 - $1,791	11 Added 2.53%	446 $59,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1,428 - $1,791	11 Added 2.53%	446 $239,000
Q3 2021 Mar 14, 2023	SELL	$106.71 - $143.18 $13,765 - $18,470	-129 Reduced 22.87%	435 $59,000
Q3 2021 Nov 04, 2021	BUY	$106.71 - $143.18 $46,418 - $62,283	435 New	435 $238,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $43,992 - $58,938	-564 Closed	0 $0
Q3 2020 Mar 14, 2023	BUY	$95.51 - $112.95 $53,867 - $63,703	564 New	564 $58,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $35,351 - $59,411	564 New	564 $229,000

1,080

351M

8.56M

5.95M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Private Portfolio Partners LLC with notifications on news.